Page last updated: 2024-09-02

oxymatrine and Ovarian Neoplasms

oxymatrine has been researched along with Ovarian Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jiang, K; Li, J; Zhao, F	1

Other Studies

1 other study(ies) available for oxymatrine and Ovarian Neoplasms

Article	Year
Oxymatrine suppresses proliferation and facilitates apoptosis of human ovarian cancer cells through upregulating microRNA‑29b and downregulating matrix metalloproteinase‑2 expression. Molecular medicine reports, 2015, Volume: 12, Issue:4 Topics: Alkaloids; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Survival; Enzyme Activation; Female; Gene Expression Regulation, Neoplastic; Humans; Matrix Metalloproteinase 2; MicroRNAs; Ovarian Neoplasms; Quinolizines; RNA Interference	2015

Article

Year

Oxymatrine suppresses proliferation and facilitates apoptosis of human ovarian cancer cells through upregulating microRNA‑29b and downregulating matrix metalloproteinase‑2 expression.

Molecular medicine reports, 2015, Volume: 12, Issue:4

Topics: Alkaloids; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Survival; Enzyme Activation; Female; Gene Expression Regulation, Neoplastic; Humans; Matrix Metalloproteinase 2; MicroRNAs; Ovarian Neoplasms; Quinolizines; RNA Interference

2015